Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Toner

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1996
Paclitaxel (Taxol) as salvage therapy for relapsed ovarian cancerR S Planner, D G Allen, A H Brand, et al.
Investigational New Drugs|November 11, 1999
A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancerD Rischin, L K Webster, M J Millward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapyI N Olver, C R Laidlaw, J P Matthews, et al.
The Journal of Urology|August 1, 1997
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study GroupE W Steyerberg, J P Donohue, A Gerl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibioticsD Rischin, S P Ackland, J Smith, et al.
British Journal of Haematology|April 1, 1996
Association of acquired Pelger-Huet anomaly with taxoid therapyS K Juneja, J P Matthews, R Luzinat, et al.
The Medical Journal of Australia|September 9, 2000
A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysisD Rischin, M A White, J P Matthews, et al.
Australian and New Zealand Journal of Medicine|February 1, 1997
Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancerJ D Shapiro, M J Millward, D Rischin, et al.
The Medical Journal of Australia|May 11, 2001
The management of testicular cancer in Victoria, 1988-1993. Urology Study Committee of the Victorian Co-operative Oncology GroupG C Toner, G J Neerhut, M A Schwarz, et al.
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1996
Paclitaxel (Taxol) as salvage therapy for relapsed ovarian cancerR S Planner, D G Allen, A H Brand, et al.
Investigational New Drugs|November 11, 1999
A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancerD Rischin, L K Webster, M J Millward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapyI N Olver, C R Laidlaw, J P Matthews, et al.
The Journal of Urology|August 1, 1997
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study GroupE W Steyerberg, J P Donohue, A Gerl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibioticsD Rischin, S P Ackland, J Smith, et al.
British Journal of Haematology|April 1, 1996
Association of acquired Pelger-Huet anomaly with taxoid therapyS K Juneja, J P Matthews, R Luzinat, et al.
The Medical Journal of Australia|September 9, 2000
A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysisD Rischin, M A White, J P Matthews, et al.
Australian and New Zealand Journal of Medicine|February 1, 1997
Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancerJ D Shapiro, M J Millward, D Rischin, et al.
The Medical Journal of Australia|May 11, 2001
The management of testicular cancer in Victoria, 1988-1993. Urology Study Committee of the Victorian Co-operative Oncology GroupG C Toner, G J Neerhut, M A Schwarz, et al.
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
Pageof 6